Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Seizures × CNS × Clear all

Phase

Status

Completed 11 Recruiting 5 Unknown 2 Withdrawn 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 79 Brain Neoplasms 75 Glioma 61 Neoplasms 16 Neuroblastoma 12 Meningioma 12 Meningeal Carcinomatosis 12 Carcinoma, Non-Small-Cell Lung 10 Medulloblastoma 9 Central Nervous System Neoplasms 9 Neurofibromatosis 1 8 Ependymoma 7 Diffuse Intrinsic Pontine Glioma 6 Breast Neoplasms 6 Recurrence 5 Astrocytoma 5 Neurologic Manifestations 4 Neurofibroma, Plexiform 4 Spinal Cord Neoplasms 3 Sarcoma 3 Ovarian Neoplasms 3 Oligodendroglioma 3 Neurofibrosarcoma 3 Lung Neoplasms 3 Ganglioneuroblastoma 3 Wilms Tumor 2 Stress, Psychological 2 Stomach Neoplasms 2 Rhabdoid Tumor 2 Prostatic Neoplasms 2

Interventions

Levetiracetam 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05897658 2024-10-23

LeviTaTe Pilot

Hamilton Health Sciences Corporation

Phase 3 Not yet recruiting

Brain Neoplasms, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡